Study of upadacitinib for teens with severe hair loss
Treatments studied
Part of Skin clinical trials.
This study tests if upadacitinib can help young people with severe alopecia areata (a condition causing patchy hair loss) regrow their hair. It may be an option if hair loss has been present for less than 8 years and there has been no recent improvement.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a child or teenager (under 18 years old)
- You have severe hair loss from alopecia areata (at least 50% of scalp hair missing)
- Your hair has not regrown on its own in the last 6 months
- Your current hair loss episode started less than 8 years ago
- You do not have other types of hair loss or scalp conditions that could affect the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a medicine called ritlecitinib for children with severe alopecia areata (a condition causing hair loss). It is for kids who have already completed a previous study of this medicine to see how well it works and how safe it is over a longer period.
This trial tests an oral medication called SYHX1901 for people with severe alopecia areata (at least 50% scalp hair loss). It aims to see if the drug can help hair regrow and is safe. It might be an option if your hair loss started less than 10 years ago and hasn't improved naturally in the last 6 months.
This study tests an oral tablet called upadacitinib for people with severe alopecia areata who have lost at least half of their scalp hair. It aims to see if the drug can safely help hair regrow.
This trial tests an experimental tablet for teenagers with severe alopecia areata, a condition causing patchy hair loss. The treatment may help regrow hair with clearer information about safety and effectiveness.
This study tests an investigational oral medication (deuruxolitinib) for adolescents with severe alopecia areata (hair loss). It aims to see if it can help hair regrow safely.
This study tests whether a new drug called LY4005130 can help regrow hair in adults with severe alopecia areata (an autoimmune condition causing patchy or widespread hair loss). The trial is looking for people who have lost a significant amount of hair and haven't seen it grow back on its own for at least 6 months.
Hear when a new Severe Alopecia Areata trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.